D050613Chemicals & DrugsD12.776.157.530.450.074.750.750.750.124D12.776.157.530.450.625.625.750.124D12.776.157.648.500.750.750.124D12.776.543.585.450.074.750.750.750.124D12.776.543.585.450.625.625.750.124110.999515Sodium-Phosphate Cotransporter Proteins, Type IIacmhprofilesont:personsuffixperson suffixprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonPhD, CGCEmilyFarrowEmily G. Farrow0.000000000000000.00000000000000124Farrow, EmilyDirector of Lab Operations0.09698690.09698691research area of0.0970340.0970341subject area for20675303Farrow EG, Summers LJ, Schiavi SC, McCormick JA, Ellison DH, White KEThe Journal of endocrinologyFarrow EG, Summers LJ, Schiavi SC, McCormick JA, Ellison DH, White KE. Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation. J Endocrinol. 2010 Oct; 207(1):67-75.J Endocrinol2010-07-30T00:00:002010Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation.PediatricsClinicalChildren's Mercy Kansas Citytrue1Director of Lab OperationsDirector of Lab Operations